Physiological Performance of a Detergent Decellularized Heart Valve Implanted for 15 Months in Vietnamese Pigs: Surgical Procedure, Follow-up, and Explant Inspection

Artificial Organs

Volumn 36, Issue 6, 2012, Pages

  Gallo, Michele ^a   Naso, Filippo ^a   Poser, Helen ^a   Rossi, Antonio ^b   Franci, Paolo ^a   Bianco, Roberto ^c   Micciolo, Matteo ^c   Zanella, Fabio ^c   Cucchini, Umberto ^c   Aresu, Luca ^a   Buratto, Edward ^a   Busetto, Roberto ^a   Spina, Michele ^a   Gandaglia, Alessandro ^a   Gerosa, Gino ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Animal model; Decellularization; Heart valves; Swine; Tissue engineering; Translational research

Indexed keywords

ANIMALS; BIOMINERALIZATION; BLOOD VESSELS; ECHOCARDIOGRAPHY; HEART; NUCLEIC ACIDS; PHYSIOLOGICAL MODELS; SURGERY; TISSUE;

ANIMAL MODEL; DECELLULARIZATION; DECELLULARIZED; FOLLOW UP; HEART VALVES; PERFORMANCE; SWINE; TISSUES ENGINEERINGS; TRANSLATIONAL RESEARCH; VIETNAMESE;

TISSUE ENGINEERING;

CHOLIC ACID; TRITON X 100;

ANASTOMOSIS; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; AORTA VALVE; AORTA VALVE REGURGITATION; ARTICLE; ARTIFICIAL EMBOLISM; CALCIFICATION; CONTROLLED STUDY; CORONARY HEMODYNAMICS; DISEASE MODEL; DNA CONTENT; EXCISION; EXPLANT; EXTRACELLULAR MATRIX; FEMALE; FOLLOW UP; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VALVE REPLACEMENT; HYPOKALEMIA; HYPOTHERMIA; LUNG ARTERY; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SHAM PROCEDURE; SURGICAL TECHNIQUE; SWINE; TISSUE ENGINEERING; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANIMALIA; SUIDAE; SUS;

EID: 84862159860     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2012.01447.x     Document Type: Article

References (58)

1. Roger VL, Go AS, Lloyd-Jones DM, etal. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011;123:e18-209.
2. Vesely I. Heart valve tissue engineering. Circ Res 2005;97:743-55.
3. Schleicher M, Wendel HP, Fritze O, Stock UA. In vivo tissue engineering of heart valves: evolution of a novel concept. Regen Med 2009;4:613-9.
4. Simon P, Kasimir MT, Seebacher G, etal. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in paediatric patients. Eur J Cardiothorac Surg 2003;23:1002-6.
5. Schoen FJ. Heart valve tissue engineering: quo vadis? Curr Opin Biotechnol 2011;22:1-8.
6. Brody S, Pandit A. Approaches to heart valve tissue engineering scaffold design. J Biomed Mater Res 2007;83:16-43.
7. Gallegos RP, Nockel PJ, Rivard AL, Bianco RW. The current state of in vivo pre-clinical animal models for heart valve evaluation. J Heart Valve Dis 2005;14:423-32.
8. Knight RL, Wilcox HE, Korossis SA, Fisher J, Ingham E. The use of acellular matrices for the tissue engineering of cardiac valves. Proc Inst Mech Eng [H] 2008;222:129-43.
9. Erdbrügger W, Konertz W, Dohmen PM, etal. Decellularized xenogenic heart valves reveal remodelling and growth potential in vivo. Tissue Eng 2006;12:2059-68.
10. Bastian F, Stelzmüller ME, Kratochwill K, Kasimir MT, Simon P, Weigel G. IgG deposition and activation of the classical complement pathway involvement in the activation of human granulocytes by decellularized porcine heart valve tissue. Biomaterials 2008;29:1824-32.
11. Schopka S, Schmid FX, Hirt S, Birnbaum DE, Schmid C, Lehle K. Recellularization of biological heart valves with human vascular cells: in vitro haemocompatibility assessment. J Biomed Mater Res B Appl Biomater 2009;88:130-8.
12. Fang NT, Xie SZ, Wang SM, Gao HY, Wu CG, Pan LF. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Chin Med J (Engl) 2007;120:696-702.
13. Stock UA, Schenke-Layland K. Performance of decellularized xenogeneic tissue in heart valve replacement. Biomaterials 2006;27:1-2.
14. Iwai S, Torikai K, Coppin CM, Sawa Y. Minimally immunogenic decellularized porcine valve provides in situ recellularization as a stentless bioprosthetic valve. J Artif Organs 2007;10:29-35.
15. Gregoric I, Conger JL, Reul H, etal. Preclinical assessment of a trileaflet mechanical valve in the mitral position in a calf model. Ann Thorac Surg 2004;77:196-202.
16. Jones RD, Akao M, Cross FS. Bacteremia and thrombus on prosthetic heart valves in dogs. Circulation 1969;39:I253-6.
17. Ali ML, Kumar SP, Bjornstad K, Duran CM. The sheep as an animal model for heart valve research. Cardiovasc Surg 1996;4:543-9.
18. Gottlieb D, Kunal T, Emani S, etal. In vivo monitoring of function of autologous engineered pulmonary valve. J Thorac Cardiovasc Surg 2010;139:723-31.
19. Hopkins RA, Jones AL, Wolfinbarger L, Moore MA, Bert AA, Lofland GK. Decellularization reduces calcification while improving both durability and 1-year functional results of pulmonary homograft valves in juvenile sheep. J Thorac Cardiovasc Surg 2009;137:907-13.
20. Butcher JT, Mahler GJ, Hockaday LA. Aortic valve disease and treatment: the need for naturally engineered solutions. Adv Drug Deliv Rev 2011;63:242-68.
21. Thein E, Hammer C. Physiologic barriers to xenotransplantation. Curr Opin Organ Transplant 2004;9:186-9.
22. Boluyt MO, Cirrincione GM, Loyd AM, Korzick DH, Parker JL, Laughlin MH. Effects of gradual coronary artery occlusion and exercise training on gene expression in swine heart. Mol Cell Biochem 2007;294:87-96.
23. Turk JR, Henderson KK, Vanvickle GD, Watkins J, Laughlin MH. Arterial endothelial function in a porcine model of early stage atherosclerotic vascular disease. Int J Exp Pathol 2005;86:335-45.
24. Crick SJ, Sheppard MN, Ho SY, Gebstein L, Anderson RH. Anatomy of the pig heart: comparisons with normal human cardiac structure. J Anat 1998;193:105-19.
25. Goodman SL. Sheep, pig, and human platelet-material interactions with model cardiovascular biomaterials. J Biomed Mater Res 1999;45:240-50.
26. Schuleri KH, Boyle AJ, Centola M, etal. The adult Göttingen minipig as a model for chronic heart failure after myocardial infarction: focus on cardiovascular imaging and regenerative therapies. Comp Med 2008;58:568-79.
27. Linkenhoker JR, Burkholder TH, Linton CG, etal. Effective and safe anesthesia for Yorkshire and Yucatan swine with and without cardiovascular injury and intervention. J Am Assoc Lab Anim Sci 2010;49:344-51.
28. ISO 10993-2. Biological evaluation of medical devices. Part 2: animal welfare requirements. EN ISO 10993, 2003.
29. Spina M, Ortolani F, El Messlemani A, etal. Isolation of intact aortic valve scaffolds for heart-valve bioprostheses: extracellular matrix structure, prevention from calcification, and cell repopulation features. J Biomed Mater Res A 2003;67:1338-50.
30. Bertipaglia B, Ortolani F, Petrelli L, etal. Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO Project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur). Ann Thorac Surg 2003;75:1274-82.
31. Yeom SC, Oh BC, Cho SY, Park CG, Lee BC, Lee WJ. Investigation of blood typing method for Seoul National University miniature pig. Transplant Proc 2009;41:1921-6.
32. UNI EN ISO 5840. Cardiovascular implants-cardiac valve prostheses. Reference number EN ISO 5840, 2009.
33. ISO 10993-1. Biological evaluation of medical devices. Part 1: evaluation and testing. Reference number ISO 10993-1:2003(E), 2009.
34. Samouillan V, Lamure A, Maurel E, etal. Characterisation of elastin and collagen in aortic bioprostheses. Med Biol Eng Comput 2000;38:226-31.
35. Morales TI, Wahl LM, Hascall VC. The effect of bacterial lipopolysaccharides on the biosynthesis and release of proteoglycans from calf articular cartilage cultures. J Biol Chem 1984;259:6720-9.
36. Xing Y, Warnock JN, He Z, Hilbert SL, Yoganathan AP. Cyclic pressure affects the biological properties of porcine aortic valve leaflets in a magnitude and frequency dependent manner. Ann Biomed Eng 2004;32:1461-70.
37. Bottio T, Tarzia V, Dal Lin C, etal. The changing hydrodynamic performance of the decellularized intact porcine aortic root: considerations on in vitro testing. J Heart Valve Dis 2010;19:485-91.
38. Kanter KR, Fyfe DA, Mahle WT, Forbess JM, Kirshbom PM. Results with the freestyle porcine aortic root for right ventricular outflow tract reconstruction in children. Ann Thorac Surg 2003;76:1889-94.
39. Schmid FX, Keyser A, Wiesenack C, Holmer S, Birnbaum DE. Stentless xenografts and homografts for right ventricular outflow tract reconstruction during the Ross operation. Ann Thorac Surg 2002;74:684-8.
40. Steinhoff G, Stock U, Karim N, etal. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 2000;102:III-50-5.
41. Navarro FB, Costa FD, Mulinari LA, etal. Evaluation of the biological behavior of decellularized pulmonary homografts: an experimental sheep model. Rev Bras Cir Cardiovasc 2010;25:377-87.
42. Elkins RC, Goldstein S, Hewitt CW, etal. Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg 2001;13:I87-92.
43. Cebotari S, Lichtenberg A, Tudorache I, etal. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 2006;114:I132-7.
44. Rieder E, Seebacher G, Kasimir M, etal. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 2005;111:2792-7.
45. Iop L, Renier V, Naso F, etal. The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds. Biomaterials 2009;30:4104-16.
46. Naso F, Gandaglia A, Iop L, Spina M, Gerosa G. First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. Acta Biomater 2011;7:1728-34.
47. Baraki H, Tudorache I, Braun M, etal. Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model. Biomaterials 2009;30:6240-6.
48. De Visscher G, Vranken I, Lebacq A, etal. In vivo cellularization of a cross-linked matrix by intraperitoneal implantation: a new tool in heart valve tissue engineering. Eur Heart J 2007;28:1389-96.
49. Reverdiau-Moalic P, Watier H, Vallée I, Lebranchu Y, Bardos P, Gruel Y. Comparative study of porcine and human blood coagulation systems: possible relevance in xenotransplantation. Transplant Proc 1996;28:643-4.
50. Bodnar E. The Medtronic Parallel valve and the lessons learned. J Heart Valve Dis 1996;5:572-3.
51. Quinn RW, Hilbert SL, Bert AA, etal. Performance and morphology of decellularized pulmonary valves implanted in juvenile sheep. Ann Thorac Surg 2011;92:131-7.
52. Ishihara T, Ferrans VJ, Barnhart GR, Jones M, McIntosh CL, Roberts WC. Intracuspal hematomas in implanted porcine valvular bioprostheses: clinical and experimental studies. J Thorac Cardiovasc Surg 1982;83:399-407.
53. Gordin A, Chadha NK, Campisi P, Luginbuehl I, Taylor G, Forte V. Effect of a novel anatomically shaped endotracheal tube on intubation-related injury. Arch Otolaryngol Head Neck Surg 2010;136:54-9.
54. Kaiser GM, Heuer M, Frühauf NR, Kühne CA, Broelsch CE. General handling and anesthesia for experimental surgery in pigs. J Surg Res 2006;130:73-9.
55. Marchini M, Ortolani F, Bonetti A, etal. Spontaneous cell repopulation of valved aortic conduits after decellularization and allogeneic transplantation. Oral communication C26, 3rd Biennial Heart Valve Biology and Tissue Engineering Meeting, The Royal Society London 4th-7th May, 2008.
56. Layland KS. From tissue engineering to regenerative medicine-the potential and the pitfalls. Adv Drug Deliv Rev 2011;63:193-4.
57. Gandaglia A, Spina M, Naso F, etal. Heart valve regeneration: twelve months results of cell repopulation of valved aortic conduits after decellularization and allogeneic transplantation. Abstract number 1187432, XXXV Annual meeting of European Society for Artificial Organs, 3rd-6th September 2008, Geneve, Switzerland.
58. Cebotari S, Tudorache I, Ciubotaru A, etal. Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report. Circulation 2011;124(11 Suppl.):S115-23.